Assessment of the Expected Equivalent Doses of Thyroid Radiation to Personnel Upon Inhalation of Iodine-123 Radionuclide

24 September 2026Original research1 min read

By Vladimir Firsanov, Dar'ya Arefeva, Aleksandra Petushok and 1 others.

Abstract

Currently, radiopharmaceuticals based on iodine-123 are intensively used in medicine to diagnose thyroid cancer, study brain perfusion, insulin metabolism, and in many other areas. In the manufacture of sources based on iodine-123, it is possible for it to enter the thyroid gland of personnel performing these works. The article provides an assessment procedure for the expected quivalent doses of thyroid radiation to personnel upon inhalation of radionuclide

Keywords

Radiation Dose and Imaging
Thyroid
Inhalation
Radionuclide
Radiation exposure
Radioactive iodine
Radionuclide imaging
Radiation dose
Open access

Authors

Vladimir Firsanov
Dar'ya Arefeva
Aleksandra Petushok
V Gudymenko

Source

Published in ANRI. The abstract is shown as published and remains the work of its authors; read the full article at the source.

doi.org/10.37414/2075-1338-2026-125-2-46-57

Prognia lists this article for reference and education. It is not medical advice. Always read the original and follow current guidelines and local protocols before acting on it.

Assessment of the Expected Equivalent Doses of Thyroid Radiation to Personnel Upon Inhalation of Iodine-123 Radionuclide

Abstract

Keywords

Authors

Source

Read around a topic while you study.

At a glance